April 18, 2026 · Part 1 of 7
What Is Diabetes, Really?
The glucose-insulin axis, why diabetes is not one disease, and the lifestyle factor most patients underestimate.
Practical health information from the Premonition Health care team — written for patients, not for charts.
Latest Guides · April 28, 2026
Healthcare Navigation
Medicare's alphabet soup explained — what each part covers, why hospitals are dropping Advantage plans, Medigap F vs. G vs. N, enrollment windows, and the late penalties no one warned you about.
Read the guide →Healthcare Navigation
The price your pharmacy quotes you is often not the lowest price available. A practical guide organized by coverage type — uninsured, commercial insurance, Medicaid, and Medicare — with an interactive decision tree.
Read the guide →Previous Series
A 7-post series covering the glucose-insulin axis, diabetes types, treatment options, complications, diet, exercise, and monitoring — what the evidence actually shows.
Previous Series
A 14-post series in three sub-series: thyroid, testosterone, and estrogen & MHT. View hormone hub →
Set 1 — Thyroid (4 posts)
Set 2 — Testosterone (5 posts)
Set 3 — Estrogen & MHT (5 posts)
Series · Diabetes
April 18, 2026 · Part 1 of 7
The glucose-insulin axis, why diabetes is not one disease, and the lifestyle factor most patients underestimate.
April 18, 2026 · Part 2 of 7
How each type of diabetes works, what distinguishes LADA and MODY, and why getting the diagnosis right changes everything.
April 18, 2026 · Part 3 of 7
Why GLP-1 agonists and SGLT2 inhibitors have changed the treatment landscape — and how to choose the right medication for the right patient.
April 18, 2026 · Part 4 of 7
How sustained high glucose damages organs over time, what the A1c thresholds actually mean, and how targets should be individualized.
April 18, 2026 · Part 5 of 7
What the randomized trial evidence shows across dietary patterns — and why diet and medication work together, not instead of each other.
April 18, 2026 · Part 6 of 7
Why sustainability beats intensity, what the weekend warrior data shows, and how exercise works differently in Type 1 and Type 2.
April 18, 2026 · Part 7 of 7
CGM vs. fingerstick, time-in-range targets, automated insulin delivery, and what to do in a glucose emergency.
Series · Thyroid
April 12, 2026 · Thyroid Series · Post 1 of 4
The HPT axis, what TSH actually measures, why T4 isn't T3, and what "normal" thyroid function really means.
April 12, 2026 · Thyroid Series · Post 2 of 4
Overt vs. subclinical hypothyroidism, T4 monotherapy vs. T4/T3 combinations, dose targets, and the monitoring schedule that actually makes sense.
April 12, 2026 · Thyroid Series · Post 3 of 4
Graves' disease, toxic nodules, thyroiditis — causes, symptoms, treatment options, and when thyroid nodules require biopsy versus watchful waiting.
April 12, 2026 · Thyroid Series · Post 4 of 4
Adrenal fatigue, reverse T3, Wilson's syndrome, and why the TSH range isn't a conspiracy — what functional medicine thyroid claims actually look like under scrutiny.
Series · Testosterone
April 12, 2026 · Testosterone Series · Post 1 of 5
How testosterone is made, what it regulates, what normal ranges mean, and why the energy-libido-vitality narrative is more complicated than the wellness industry admits.
April 12, 2026 · Testosterone Series · Post 2 of 5
When testosterone replacement is actually indicated, which formulations work best, what labs to check and when, and how to have honest conversations about fertility.
April 12, 2026 · Testosterone Series · Post 3 of 5
The one FDA-recognized indication for testosterone in women, what the evidence shows for energy and mood, safe dosing ranges, and why supraphysiologic doses carry real risk.
April 12, 2026 · Testosterone Series · Post 4 of 5
Informed consent vs. gatekeeper models, what physical changes to expect and when, fertility considerations, and the monitoring schedule for masculinizing hormone therapy.
April 12, 2026 · Testosterone Series · Post 5 of 5
How testosterone marketing turned a medical condition into a lifestyle brand, what clinical trials actually show about testosterone for age-related decline, and what to watch for in a Low-T clinic.
Series · Estrogen & MHT
April 12, 2026 · Estrogen & MHT · Post 1 of 5
Perimenopause to postmenopause — the biology of the transition, how long symptoms actually last, which symptoms are directly caused by estrogen loss, and how to set realistic expectations.
April 12, 2026 · Estrogen & MHT · Post 2 of 5
What the Women's Health Initiative actually found, why it was misinterpreted for two decades, and what the evidence now shows about who benefits from MHT and when to start.
April 12, 2026 · Estrogen & MHT · Post 3 of 5
Absolute risk numbers for breast cancer, VTE, and stroke — not relative risks — plus who should take estrogen alone, extended use considerations, and clear contraindications.
April 12, 2026 · Estrogen & MHT · Post 4 of 5
Non-hormonal options for vasomotor symptoms — what actually works, what doesn't, and why vaginal estrogen belongs in a completely different conversation from systemic MHT.
April 12, 2026 · Estrogen & MHT · Post 5 of 5
Informed consent model, physical changes and timeline, what's reversible and what isn't, fertility considerations, VTE risk, and the monitoring schedule for feminizing hormone therapy.
Series · GLP-1 Medications
April 6, 2026 · Part 1 of 7
How semaglutide and tirzepatide work, what makes them different from previous weight-loss drugs, and what FDA approval actually means.
April 6, 2026 · Part 2 of 7
What the long-term trial data actually shows about GI side effects, thyroid concerns, pancreatitis risk, and who should not take these medications.
April 6, 2026 · Part 3 of 7
Real-world weight loss averages from clinical trials, how results vary by individual, and what "up to 22%" actually means in practice.
April 6, 2026 · Part 4 of 7
Why weight returns after stopping GLP-1 medications, what the STEP trial extension showed, and how to build a long-term maintenance plan.
April 6, 2026 · Part 5 of 7
How exercise and protein intake amplify GLP-1 results, protect muscle mass, and change what happens when you eventually taper the medication.
April 6, 2026 · Part 6 of 7
What compounded semaglutide actually is, the FDA's position on it, counterfeit risks, and the most common misconceptions about GLP-1 medications.
April 6, 2026 · Part 7 of 7
What the evidence shows about GLP-1 medications, PCOS, menstrual cycles, contraception interactions, and pregnancy — with clear guidance on when to stop.
Series · The Common Cold
April 1, 2026 · Part 1 of 5
What's actually happening in your body during a cold, what to expect, and why it almost always gets better on its own.
April 1, 2026 · Part 2 of 5
How a common cold can become dangerous for people with asthma, COPD, weakened immune systems, or heart disease — and which vaccinations help.
April 1, 2026 · Part 3 of 5
A frank look at cold medications: what's backed by evidence, what to skip, and why the good decongestant is behind the counter.
April 1, 2026 · Part 4 of 5
Nasal saline irrigation — the one home cold remedy with real evidence behind it. How it works, isotonic vs. hypertonic, and how to do it correctly.
April 1, 2026 · Part 5 of 5
How to tell when a cold is turning into a bacterial complication — warning signs, when to call the clinic, and when to go to the ER.
Guides · Healthcare Navigation
April 28, 2026 · Healthcare Navigation
The price your pharmacy quotes you is often not the lowest price available. A practical guide organized by coverage type — uninsured, commercial insurance, Medicaid, and Medicare.
April 28, 2026 · Healthcare Navigation
Medicare's alphabet soup explained — what each part covers, why hospitals are dropping Advantage plans, Medigap F vs. G vs. N, enrollment windows, and the late penalties no one warned you about.
April 1, 2026 · Primary Care
What membership-based primary care actually means, how it differs from a traditional practice, and whether it's a good fit for you.
No posts matched your search.